Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physical Activity Promotion + Tezepelumab in Severe Asthma
NCT07735494Recruiting
- Sponsor
- University of Leeds
- Start
- Jul 2026
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in severe asthma (2 arms), sponsored by University of Leeds. Primary endpoint: Daily step count at 3 months. Started Jul 2026; status: recruiting.
02
Conditions
severe asthma
Beyond the preview
Go deeper on NCT07735494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07735494.